GlucoTrack Statistics
Total Valuation
GlucoTrack has a market cap or net worth of $1.77 million. The enterprise value is $2.60 million.
| Market Cap | 1.77M |
| Enterprise Value | 2.60M |
Important Dates
The last earnings date was Friday, August 14, 2026, after market close.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GlucoTrack has 6.26 million shares outstanding. The number of shares has increased by 1,149.26% in one year.
| Current Share Class | 6.26M |
| Shares Outstanding | 6.26M |
| Shares Change (YoY) | +1,149.26% |
| Shares Change (QoQ) | +205.78% |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | 11.03% |
| Float | 5.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.46
| Current Ratio | 0.46 |
| Quick Ratio | 0.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -270.16 |
Financial Efficiency
Return on equity (ROE) is -620.63% and return on invested capital (ROIC) is -261.35%.
| Return on Equity (ROE) | -620.63% |
| Return on Assets (ROA) | -164.45% |
| Return on Invested Capital (ROIC) | -261.35% |
| Return on Capital Employed (ROCE) | 1,031.41% |
| Weighted Average Cost of Capital (WACC) | 4.96% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.06M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.65% in the last 52 weeks. The beta is 0.66, so GlucoTrack's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -93.65% |
| 50-Day Moving Average | 0.38 |
| 200-Day Moving Average | 1.84 |
| Relative Strength Index (RSI) | 40.16 |
| Average Volume (20 Days) | 5,148,303 |
Short Selling Information
The latest short interest is 165,864, so 2.65% of the outstanding shares have been sold short.
| Short Interest | 165,864 |
| Short Previous Month | 2.56M |
| Short % of Shares Out | 2.65% |
| Short % of Float | 2.92% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.40M |
| Pretax Income | -15.95M |
| Net Income | -15.95M |
| EBITDA | -15.33M |
| EBIT | -15.40M |
| Earnings Per Share (EPS) | -$7.52 |
Balance Sheet
The company has $1.12 million in cash and $1.96 million in debt, with a net cash position of -$835,000 or -$0.13 per share.
| Cash & Cash Equivalents | 1.12M |
| Total Debt | 1.96M |
| Net Cash | -835,000 |
| Net Cash Per Share | -$0.13 |
| Equity (Book Value) | -1.74M |
| Book Value Per Share | -0.28 |
| Working Capital | -1.61M |
Cash Flow
In the last 12 months, operating cash flow was -$16.22 million and capital expenditures -$87,000, giving a free cash flow of -$16.31 million.
| Operating Cash Flow | -16.22M |
| Capital Expenditures | -87,000 |
| Depreciation & Amortization | 66,000 |
| Net Borrowing | 4.39M |
| Free Cash Flow | -16.31M |
| FCF Per Share | -$2.61 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GlucoTrack does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,149.26% |
| Shareholder Yield | -1,149.26% |
| Earnings Yield | -903.45% |
| FCF Yield | -923.90% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 16, 2025. It was a reverse split with a ratio of 1:60.
| Last Split Date | Jun 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:60 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |